Literature DB >> 15221204

Skeletal status in adolescents with end-stage renal failure: a longitudinal study.

Wojciech Pluskiewicz1, Piotr Adamczyk, Bogna Drozdzowska, Krystyna Szprynger, Maria Szczepańska, Zenon Halaba, Dariusz Karasek.   

Abstract

In a longitudinal study, bone status was assessed in adolescents and young adults aged 15.3+/-3.4 years at the onset of the study with end-stage renal failure (ESRF). The group consisted of 18 subjects (11 females and seven males), of whom nine patients were on hemodialysis and nine patients on peritoneal dialysis. Six patients were previous or current glucocorticoid (GCS) users. Renal failure was recognized before 6.1+/-4.1 years, and dialysis was performed for 3.0+/-2.0 years. Follow-up took placed 8.6+/-0.8 and 21.7+/-2.5 months later, and the following data were collected: bone mineral density (BMD) at the spine (s-BMD) and total body (TB-BMD) using DPX-L (Lunar, USA); quantitative ultrasound by DBM 1200 (IGEA, Italy) at the hand phalanges (Amplitude-dependent Speed of Sound, Ad-SoS), serum concentration of i-PTH, total calcium, ionized calcium and phosphate. Tanner stages were also evaluated. The mean values of BMD measurements and Ad-SoS were stable during a period of observation, and a mean Z-score for TB-BMD was significantly lower at the third versus baseline value (-1.87+/-1.75 versus -1.49+/-1.53, P<0.05). Z-scores for s-BMD and Ad-SoS decreased non-significantly. Changes in s-BMD and TB-BMD Z-scores were influenced by changes in body size and changes in biochemical parameters, and a change in Ad-SoS Z-score was not dependent on these factors. The values of second (P<0.05) and third (P<0.01) s-BMD Z-score were significantly lower in GCS treated subjects, and longitudinal change in spine Z-score was greater in GCS treated patients versus others (P<0.05). Duration of ESRF, duration and type of dialysis and gender did not influence skeletal variables. Skeletal measurements correlated significantly with Tanner stages (besides the correlation with Ad-SoS in the first measurement, r ranged from 0.5 to 0.72, P<0.05), and changes in Tanner stages observed over a period of observation did not correlate with changes in skeletal variables. Among laboratory variables, the following non-significant tendencies to change were observed: serum concentration of i-PTH and phosphate increased, and total and ionized calcium decreased. In conclusion, adolescent subjects with ESRF treated with dialysis showed stable mean values of skeletal measurements, and these were expressed as Z-scores, a tendency to drop was observed. The lack of an increase observed in normal healthy subjects of the same age, and low values in Z-scores, indicates that skeletal status is seriously affected in subjects with ESRF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221204     DOI: 10.1007/s00198-004-1672-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  20 in total

1.  Monitoring skeletal changes by radiological techniques.

Authors:  C C Glüer
Journal:  J Bone Miner Res       Date:  1999-11       Impact factor: 6.741

2.  Skeletal status in children, adolescents and young adults with end-stage renal failure treated with hemo- or peritoneal dialysis.

Authors:  W Pluskiewicz; P Adamczyk; B Drozdzowska; K Szprynger; M Szczepanska; Z Halaba; D Karasek
Journal:  Osteoporos Int       Date:  2002-05       Impact factor: 4.507

3.  Severe bone disease and low bone mineral density after juvenile renal failure.

Authors:  Jaap W Groothoff; Martin Offringa; Berthe L F Van Eck-Smit; Mariken P Gruppen; Nicole J Van De Kar; Eric D Wolff; Marc R Lilien; Jean Claude Davin; Hugo S A Heymans; Friedo W Dekker
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

4.  Monitoring of bone mineral content in patients on regular hemodialysis.

Authors:  E Eeckhout; D Verbeelen; J Sennesael; L Kaufman; M H Jonckheer
Journal:  Nephron       Date:  1989       Impact factor: 2.847

Review 5.  Prevention and treatment of renal osteodystrophy in children with chronic renal insufficiency and end-stage renal disease.

Authors:  C P Sanchez
Journal:  Semin Nephrol       Date:  2001-09       Impact factor: 5.299

6.  Quantitative ultrasound and dual X-ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis.

Authors:  A Peretz; A Penaloza; M Mesquita; M Dratwa; M Verhas; P Martin; V de Maertelaer; P Bergmann
Journal:  Bone       Date:  2000-08       Impact factor: 4.398

7.  Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.

Authors:  H Ziółkowska; M Pańczyk-Tomaszewska; Z Majkowska; T Rajkowski; A Debiński; J Przedlacki; A Sawicki; K Ostrowski; A Marciński; M Roszkowska-Blaim
Journal:  Med Sci Monit       Date:  2001 Sep-Oct

8.  Bone mineral density in haemodialysis patients: A comparative study of dual-energy X-ray absorptiometry and quantitative ultrasound.

Authors:  M Arici; H Erturk; B Altun; C Usalan; S Ulusoy; Y Erdem; A Sivri; U Yasavul; C Turgan; S Caglar
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

9.  Risk factors for reduced bone density in haemodialysis patients.

Authors:  M W Taal; T Masud; D Green; M J Cassidy
Journal:  Nephrol Dial Transplant       Date:  1999-08       Impact factor: 5.992

10.  Changes in bone mineral content during long-term CAPD. Indication of a sex-dependent bone mineral loss.

Authors:  N Lyhne; F B Pedersen
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

View more
  8 in total

1.  Bone mineral density in children with chronic renal failure.

Authors:  Simon Waller; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2006-09-15       Impact factor: 3.714

2.  Remarks on quantitative ultrasound (QUS) and densitometric measurements.

Authors:  Wojciech Pluskiewicz
Journal:  Osteoporos Int       Date:  2005-07       Impact factor: 4.507

3.  Phalangeal quantitative ultrasound in 1,719 children and adolescents with bone disorders.

Authors:  A Mussa; F Porta; G Baldassarre; G Tuli; F de Terlizzi; P Matarazzo; S Einaudi; R Lala; A Corrias
Journal:  Osteoporos Int       Date:  2011-09-23       Impact factor: 4.507

4.  Volumetric bone mineral density and bone structure in childhood chronic kidney disease.

Authors:  Rachel J Wetzsteon; Heidi J Kalkwarf; Justine Shults; Babette S Zemel; Bethany J Foster; Lindsay Griffin; C Frederic Strife; Debbie L Foerster; Darlene K Jean-Pierre; Mary B Leonard
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

5.  Assessment of dual-energy X-ray absorptiometry measures of bone health in pediatric chronic kidney disease.

Authors:  Lindsay M Griffin; Heidi J Kalkwarf; Babette S Zemel; Justine Shults; Rachel J Wetzsteon; C Frederic Strife; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2012-02-16       Impact factor: 3.714

Review 6.  Pediatric DXA: clinical applications.

Authors:  Larry A Binkovitz; Paul Sparke; Maria J Henwood
Journal:  Pediatr Radiol       Date:  2007-04-13

7.  Skeletal status assessment by quantitative ultrasound and bone densitometry in children with different renal conditions.

Authors:  P Adamczyk; M Szczepanska; W Pluskiewicz
Journal:  Osteoporos Int       Date:  2018-08-20       Impact factor: 4.507

8.  Changes in bone structure and the muscle-bone unit in children with chronic kidney disease.

Authors:  Anne Tsampalieros; Heidi J Kalkwarf; Rachel J Wetzsteon; Justine Shults; Babette S Zemel; Bethany J Foster; Debbie L Foerster; Mary B Leonard
Journal:  Kidney Int       Date:  2012-10-03       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.